ERYTHROMYCIN lactobionate, eq. to 1g base, powder, vial
NST
DINJERYT1V-
Valid Article
Account code:
60000
HS Code:
300420
Last Updated on:
12/04/2024, 17:47:19
6.2.2 - Watch group antibiotics
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01FA01
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
ERYTHROMYCIN
Please always consider the MSF STD (azithromycin) before ordering a NST.
- In the WHO list of Essential Medicines 2023 (Therapeutic alternative to clarythromycin)
Therapeutic Action
Macrolide antibiotic
Indications
Second-line treatment for severe diphtheria.
Azithromycin is the preferred option as it is much better tolerated by patients, and with a once daily administration.
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
Reconstitute the powder vial with 20 ml of water for injection.
Dilute the reconstituted solution in 0.9% NaCl.
Must be given as IV infusion only (intermittent or continuous).
IV erythromycin should be replaced by erythromycin PO as soon as
possible.
Erythromycin may be used as an alternative to azithromycin in case of supply constraints.
Precautions for Use
Bolus injection (IV) push) is contraindicated.
Storage
- Below 25ºC
- After reconstitution, use the solution immediately.
![[DINJAZIT5V-] AZITHROMYCIN, 500mg, powder, vial](/web/image/product.template/582399/image_256/%5BDINJAZIT5V-%5D%20AZITHROMYCIN%2C%20500mg%2C%20powder%2C%20vial?unique=6d73e37)